ImmuneSensor Therapeutics
Dallas
About ImmuneSensor Therapeutics
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other autoimmune diseases. It is dedicated to developing new medicines that use the body's innate immune system to cure a variety of diseases. It was founded in 2019 and is based in Dallas, Texas, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $26.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: immunesensor.com
- Phone: +1 469 757 5110
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunesensor-therapeutics-69858 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.